FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of pharmaceuticals, namely a pharmacological composition for the treatment of iron deficiency anemia (IDA), containing iron (II) sulfate, characterized in that it additionally contains iron-potassium-sodium hexacyanoferrate, potassium sulfate and microcellulose in the following ratio of components, wt.%: KNaFe[Fe(CN)6] - from 20 to 65; FeSO4 - from 2 to 10; K2SO4 - from 2 to 15; microcellulose - the rest.
EFFECT: creation of a pharmacological composition for the treatment of IDA, which combines high therapeutic efficacy, good tolerance and low toxicity in comparison with existing drugs.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACOLOGICAL COMPOSITION ON BASIS OF IRON COMPOUNDS | 2016 |
|
RU2625739C1 |
| TRIVALENT IRON FUMARATE HYDRATE AS AGENT FOR TREATING IRON-DEFICIENT ANEMIA PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 1997 |
|
RU2161963C2 |
| MEDICINAL AGENT FOR ASIDEROTIC ANEMIA TREATMENT IN CHILDREN | 1994 |
|
RU2098102C1 |
| PHARMACOLOGICAL COMPOSITION BASED ON WATER-SOLUBLE POLYMETAL COMPLEXES OF POLYGALACTURONIC ACID, STIMULATING HEMATOPOIESIS PROCESS | 2019 |
|
RU2704033C1 |
| MEDICINAL AGENT FOR ASIDEROTIC ANEMIA TREATMENT | 1994 |
|
RU2098101C1 |
| AGENT WITH HEMATOPOIETIC ACTION | 2005 |
|
RU2305552C2 |
| COMPLEX COMPOUNDS OF FERRIC IRON FOR TREATMENT AND PREVENTION OF SYMPTOMS OF IRON DEFICIENCY AND IRON DEFICIENCY ANEMIA | 2013 |
|
RU2641030C2 |
| METHOD FOR IRON DEFICIENCY ANEMIA CORRECTION IN SUCKING CALVES | 2023 |
|
RU2818836C1 |
| METHOD FOR FINDING COURSE DOSE OF ELEMENTARY IRON IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY IRON DEFICIENCY | 2012 |
|
RU2478964C1 |
| METHOD OF CORRECTION OF POSTHEMORRHAPIC ANEMIA | 2017 |
|
RU2671077C1 |
